|
|
|
Volumn 12, Issue 3, 1993, Pages 283-288
|
|
Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IMMUNOGLOBULIN;
ADOLESCENT;
ADULT;
ALLOGENIC BONE MARROW TRANSPLANTATION;
ARTICLE;
BACTERIAL INFECTION;
BLOOD;
CANCER SURVIVAL;
CHILD;
CHILL;
CYTOMEGALOVIRUS INFECTION;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG MEGADOSE;
FEMALE;
FEVER;
GRAFT VERSUS HOST REACTION;
HUMAN;
INTERSTITIAL PNEUMONIA;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKEMIA;
MAJOR CLINICAL STUDY;
MALE;
MYCOSIS;
RASH;
RELAPSE;
SEROCONVERSION;
TACHYCARDIA;
ADOLESCENT;
ADULT;
BACTERIAL INFECTIONS;
BLOOD TRANSFUSION;
BONE MARROW TRANSPLANTATION;
CHILD;
CHILD, PRESCHOOL;
CYTOMEGALOVIRUS INFECTIONS;
FEMALE;
GRAFT VS HOST DISEASE;
HUMAN;
IMMUNOGLOBULINS, INTRAVENOUS;
INCIDENCE;
LUNG DISEASES, INTERSTITIAL;
MALE;
MIDDLE AGE;
MYCOSES;
PROSPECTIVE STUDIES;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, P.H.S.;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
|
EID: 0027267754
PISSN: 02683369
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (31)
|
|
References (0)
|
